You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.1% , 1M : -4.6%,1Y : 85.1%
BOM : 500302     NSE : PEL    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
May 07,2021
Price(EOD): Rs. 1,670.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 37,668.65 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
PIRAMAL ENTERPRISES -2.1% -4.6% 85.1%
SUN PHARMACEUTICAL INDUSTRIES 6% 11.9% 38.7%
DR REDDYS LABORATORIES -0.2% 12% 33.9%
DIVIS LABORATORIES -1.1% 9.2% 77.2%
CIPLA -2.9% 5.6% 49.3%
BIOCON 0.7% -8% 7.5%
AUROBINDO PHARMA 4.6% 13.5% 52.4%
LUPIN 11.5% 14.7% 44.7%
TORRENT PHARMACEUTICALS 5% 2.9% 5.5%


FUNDAMENTAL ANALYSIS OF PIRAMAL ENTERPRISES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than PIRAMAL ENTERPRISES Premium


VALUATION OF PIRAMAL ENTERPRISES

 
Valuation Score
Ratio Consolidated
P/E
P/B
P/S
1561.17
P/E Calculated based on EPS of 1.07
[ Mar2020 - Consolidated Results ]

1.23
P/B Calculated based on Book Value of 1355.42
[ Mar2020 - Consolidated Results ]

2.95
P/S Calculated based on Revenues of 12748.8 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than PIRAMAL ENTERPRISES Premium


FAIR VALUE OF PIRAMAL ENTERPRISES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-26%
92%
-0%

SHARE PRICE MOMENTUM OF PIRAMAL ENTERPRISES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.47
0.9
0.68
0.68
1.38
2.06
1.66
1.7
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-4.04%
-5.45%
9.11%
12.79%
-3.1%
-10.74%
10.46%
19.62%
QtrlyTrend
0
Latest Qtr: Dec2020

PIRAMAL ENTERPRISES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX NEXT 50 1.7% 2.1% 62.7%
S&P BSE FINANCE 1.6% 1.9% 62%
S&P BSE LARGECAP 1.5% 1.4% 59%
S&P BSE 100 LARGECAP TMC 1.4% 1.3% 59.2%
S&P BSE LARGE MIDCAP 1.4% 1.3% 61.6%
S&P BSE 200 1.4% 1.4% 62.8%
S&P BSE CARBONEX 1.4% 1.2% 61.2%
S&P BSE 250 LARGEMIDCAP 1.4% 1.4% 63.2%
S&P BSE ALLCAP 1.4% 1.9% 66.8%
S&P BSE 500 1.3% 1.7% 65.5%
S&P BSE 100 1.3% 1.1% 59.5%
S&P BSE 100 ESG INDEX 1.3% 1.2% 64.7%
NSE Indices1W1M1Y
NIFTY NEXT 50 2.2% 3.2% 55.1%
NIFTY 100 EQUAL WEIGHT 2% 3.4% 69.3%
NIFTY FINANCE 1.6% 2.4% 60.9%
NIFTY 100 1.4% 1.3% 58.3%
NIFTY 200 1.4% 1.4% 61.8%
NIFTY 500 1.4% 1.7% 65%
NIFTY LARGE MIDCAP 250 1.2% 1.7% 72.6%

FAQ [Frequently Asked Questions]


Is PEL good for long term investment?

As on 07-May-2021, the Fundamentals of PEL are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of PIRAMAL ENTERPRISES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PEL UnderValued or OverValued?

As on 07-May-2021, PEL is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of PEL ?

As on 07-May-2021, the Intrinsic Value of PEL is Rs. 1,673.46 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,251.54
Fair Value [Median EV / Sales Model] : Rs. 867.83
Fair Value [Median Price / Sales Model] : Rs. 1,673.46
Median Fair Value of PEL : Rs. 1,673.46

Is PEL trading at a Premium or Discount?

As on 07-May-2021, PEL is trading at a Discount of -0% based on the Median Intrinsic Value!

Is it right time to buy PEL shares?

As on 07-May-2021, PEL is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Financial Performance of Industry Peers of PEL?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with PEL?

PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
PIRAMAL ENTERPRISES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z